Low density lipoprotein cholesterol levels and amino acid substitutions in HCV core region are important pretreatment predictors of response to treatment with peginterferon plus ribavirin in Japanese patients with chronic hepatitis C

憲夫, 芥田; 文孝, 鈴木; 祐介, 川村; 寛美, 八辻; ひとみ, 瀬崎; 義之, 鈴木; 哲也, 保坂; 正宏, 小林; 万利子, 小林; 康司, 荒瀬; 健次, 池田; 博光, 熊田

doi:10.2957/kanzo.47.450

Kanzo

2006

DOI: 10.2957/kanzo.47.450

|View full text |Cite

Low density lipoprotein cholesterol levels and amino acid substitutions in HCV core region are important pretreatment predictors of response to treatment with peginterferon plus ribavirin in Japanese patients with chronic hepatitis C

芥田憲夫¹,

鈴木文孝²,

川村祐介³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2007

2008

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Low density lipoprotein cholesterol levels and amino acid substitutions in HCV core region are important pretreatment predictors of response to treatment with peginterferon plus ribavirin in Japanese patients with chronic hepatitis C

Cited by 2 publications

References 5 publications

Re-evaluation of chronic hepatitis C patients who showed viral relapse after interferon plus ribavirin therapy by COBAS AmpliPrep/ COBAS Taq Man HCV Test

Re-evaluation of chronic hepatitis C patients who showed viral relapse after interferon plus ribavirin therapy by COBAS AmpliPrep/ COBAS Taq Man HCV Test

Efficacy of Pegylated Interferon and Ribavirin Combination Therapy in Chronic Hepatitis C and Influence of Lipid Factors

Contact Info

Product

Resources

About